The market of Adderall B974 – a scheduled treatment at 30mg – presents complex problems within Oz. While not officially approved for use by the Pharmaceutical Goods Administration, anecdotal evidence suggest its importation via unofficial channels. This restricted presence fuels concerns regarding safety, potential diversion, and the shortage o